Skip to main content
. 2014 Jul 29;22(1):40–45. doi: 10.1245/s10434-014-3892-2

Fig. 1.

Fig. 1

SLN mapping with [99mTc]tilmanocept/VBD (blue bars) resulted in the removal of fewer total lymph nodes compared to fTcSC/VBD (yellow bars)